¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"blood enzyme level"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® white blood cell(WBC), leukocyte ÇÑ±Û ¹éÇ÷±¸
¼³¸í   
  Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, È¤Àº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀΠÇö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù.
¿µ¹® whole blood ÇÑ±Û ÀüÇ÷, ¿ÂÇ÷¾×
¼³¸í   
  Ç÷¾×ÀÇ ¸ðµç ¼ººÐÀÌ Çϳªµµ Á¦°ÅµÇÁö ¾ÊÀº ¿ÂÀüÇÑ Ç÷¾×. ÀüÇ÷Àº ¾ö°ÝÇÑ ¹«±ÕÁ¶°ÇÇÏ¿¡¼­, ¼±º°ÇÑ °øÇ÷ÀڷκÎÅ͠äÃëÇÑ °ÍÀ̸ç, ±¸¿¬»ê ÀÌ¿ÂÀ̳ª ÇìÆÄ¸° °°Àº Ç×ÀÀ°øÁ¦·Î ÀÀ°í¸¦ ¹æÁöÇÏ¿© Ç÷¾×º¸Ãæ ¸ñÀûÀ¸·Î »ç¿ëÇÑ´Ù.
¿µ¹® blood collection ÇÑ±Û Ã¤Ç÷
¼³¸í   
  1. ¸ð¼¼°üÇ÷ : Ç÷±¸¼ö-Ç÷¼ÒÆÇ¼ö °è»ê, Ç÷»ö¼Ò·®, Ç÷±¸¿ëÀûÃøÁ¤, µµ¸»Ç¥º»Á¦ÀÛ µîÀ» ÇÒ¶§ »ç¿ëµÈ´Ù. ±ÓºÒ ¶Ç´Â ¼Õ°¡¶ô³¡¹Ù´Ú¸éÀ» ÃæºÐÈ÷ ¸¶ÂûÇÑ ´ÙÀ½, ¾ËÄڿ÷Π¼Òµ¶-°ÇÁ¶½ÃÄѼ­, ÀÛÀº Ä® ¶Ç´Â Á¾µÎħ È¤Àº 1mmÀÇ ÁÖ»çħÀ¸·Î 2~3mmÀÇ ±íÀ̱îÁö Â´Ù. ¸ÇóÀ½ Çǹæ¿ïÀº ´Û¾Æ³½ ÈÄ ´ÙÀ½ Ç͹æ¿ïÀ» °Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù. 2. Á¤¸ÆÇ÷ : ´ë·®ÀÇ Ç÷¾×À» ¿äÇϴ °æ¿ì¿¡ »ç¿ëÇÑ´Ù. º¸Åë (ÆÈ²ÞÄ¡Á¤ÁßÇǺÎ)ÁÖÁ¤ÁßÇÇÁ¤¸ÆÀ» Â¸ç, ¿µÀ¯¾ÆÀÇ °æ¿ì¿¡´Â ¿Ü°æÁ¤¸ÆÀ» ¼±ÅÃÇϱ⵵ ÇÑ´Ù. ÁöÇ÷¿ë °í¹«ÁٷΠ»ó´ÜÀ» ÃÖÀúÇ÷¾Ð¿¡ »ó´çÇϴ Á¤µµ·Î ¹­°í, ÁÖ¸ÔÀ» ²À Áã°Ô ÇÏ¿© Á¤¸ÆÀ» ³ëÃâ½ÃŲ ÈÄ ¸ê±Õ°ÇÁ¶ÁÖ»ç±â¸¦ Ç÷°ü³»¿¡ »ðÀÔÇÑ´Ù. °ð ¹Ù·Î °í¹«ÁÙ°ú ÁÖ¸ÔÀ» Ç®°í Ã¤Ç÷À» ÇÑ ´ÙÀ½ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö´Â´Ù. 2ºÐÀÌ»óÀÇ Á¤¸Æ ¿ïÇ÷Àº Ç÷¾×¼º»ó¿¡ º¯È­¸¦ °¡Á®¿Â´Ù. 2. µ¿¸ÆÇ÷ : À§ÆÈµ¿¸Æ ¶Ç´Â ³Ò´Ù¸® µ¿¸ÆÀ» »ç¿ëÇÏ¿© ÃµÀںθ¦ ¼Òµ¶ÇÑ ´ÙÀ½, ÇÁ·ÎÄ«ÀΠ±¹¼Ò¸¶Ã븦 ÇÑ´Ù. Ã¤Ç÷ÀÚ ¿Þ¼ÕÀÇ °¡¿îµ¥¼Õ°¡¶ô°ú µÑ°¼Õ°¡¶ôÀ¸·Î µ¿¸ÆÀ» °íÁ¤Çϰí, ÁÖ»çħÀ» µ¿¸Æ¿¡ 45~65¡ÉÀÇ °¢µµ·Î Âñ·¯ ³Ö¾î Ã¤Ç÷ ÈÄ ¸öÂʵ¿¸ÆÀ» ¾öÁö¼Õ°¡¶ôÀ¸·Î ¾Ð¹ÚÇϸ鼭 ÁÖ»çħÀ» »©°í, ±× µÚ 5ºÐ°£Âë Â ºÎÀ§¸¦ ¾Ð¹ÚÇÑ´Ù.
¿µ¹® blood vessel ÇÑ±Û Ç÷°ü
¼³¸í   
  Ç÷¾×ÀÌ ´Ù´Ï´Â ±æ. µ¿¸Æ, ¸ð¼¼Ç÷°ü, Á¤¸ÆÀ¸·Î ±¸¼ºµÈ´Ù. µ¿¸ÆÀº ½ÉÀå¿¡¼­ ³ª°¡´Â ÇǸ¦ ¿î¹ÝÇϴ Ç÷°ü. À̰ÍÀº ½ÉÀå¿¡¼­ ³ª°¡´Â ÇǸ¦ ¿î¹ÝÇϴ Ç÷°üÀ̸砽ÉÀå¿¡¼­ Á÷Á¢ ¸¹Àº ¾Ð·ÂÀ» ¹Þ¾Æ¾ß ÇϹǷΠ¸¹Àº ¿¬Á¶Á÷°ú Åº¼º¼¶À¯·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. À̰ÍÀº Å©±â¿Í ±× Çö¹Ì°æÀû ±¸Á¶¿¡ µû¶ó ´ÙÀ½°ú °°ÀÌ ³ª´«´Ù. ´ëµ¿¸Æ(¿Þ½É½Ç¿¡¼­ Á÷Á¢ ³ª¿À´Â µ¿¸Æ. ¿Â¸öÀÇ Ç÷¾× ¼øÈ¯ÀÇ Áٱ⿪ÇÒÀ» ÇÑ´Ù), µ¿¸Æ(´ëµ¿¸Æ¿¡¼­ ºÐÁö¸¦ ³½ Áß°£ Å©±âÀÇ µ¿¸Æ), ¼¼µ¿¸Æ(µ¿¸Æ¿¡¼­ ºÐÁö¸¦ ³½ ÀÛÀº µ¿¸ÆÀ» ¸»ÇÑ´Ù)À¸·Î ³ª´«´Ù.
  
  ¸ð¼¼Ç÷°ü(capillary)Àº ÇÑÃþÀÇ ¼¼Æ÷·Î ÀÌ·ç¾îÁø ¾ãÀº Ç÷°ü. À̰ÍÀ» ÅëÇØ¼­ ¿µ¾çºÐ°ú »ê¼ÒÀÇ À̵¿, ³ëÆó¹°ÀÇ À̵¿ µîÀÌ ÀÌ·ç¾îÁø´Ù.
  
  Á¤¸Æ(vein)Àº ½ÉÀåÀ¸·Î µé¾î¿À´Â Çǰ¡ È帣´Â Åë·Î. µ¿¸Æ¿¡ ºñÇØ¼­ Ç÷°üÀÇ º®ÀÌ ¾ã°í Ç÷¾×ÀÇ ¿ª·ù¸¦ ¹æÁöÇϱâ À§ÇÑ ÆÇ¸·ÀÌ Á¸ÀçÇϴ °ÍÀ̠Ư¡ÀÌ´Ù. À̰ÍÀº ½ÉÀå¿¡¼­ Á÷Á¢ ¾Ð·ÂÀ» ¹ÞÁö ¾Ê±â¶§¹®¿¡ Ç÷¾×ÀÌ ¿ª·ùÇÒ ¼öµµ ÀÖ°í ¶Ç Ç÷°üº®ÀÌ ¾ã¾Æµµ µÇ±â ¶§¹®ÀÌ´Ù. Å©±â¿Í Çö¹Ì°æÀû ±¸Á¶¿¡ µû¶ó ´ëÁ¤¸Æ(½ÉÀå°ú Á÷Á¢ ¿¬°áµÇ´Â Á¤¸Æ), Á¤¸Æ(´ëÁ¤¸Æ¿¡ À̸£±âÀü Áß°£ ±½±âÀÇ Á¤¸Æ), ¼¼Á¤¸Æ(¸ð¼¼Ç÷°ü°ú Á÷Á¢ ¿¬°áµÇ¾î Àִ ÀÛÀº ±½±âÀÇ Á¤¸Æ)À¸·Î ³ª´«´Ù.
  
  Ç÷°ü
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximal inspiratory level
    ÃÖ´ëµé¼û¼öÁØ, ÃÖ´ëÈí±â°ª
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • noise level
    ¼ÒÀ½¼öÁØ, ÀâÀ½µµ
  • no-observed-effect level
    ¹«°üÂûÈ¿°ú¼öÁØ
  • peak level
    ÃÖ°íÄ¡
  • permissible radiation exposure level
    Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
  • saturation sound pressure level
    Æ÷È­¼Ò¸®¾Ð¼öÁØ, Æ÷È­À½¾Ð¼öÁØ
  • sound level meter
    1. À½·®¼öÁذè 2. ¼ÒÀ½°è
  • sound pressure level
    ¼Ò¸®¾Ð¼öÁØ, À½¾Ð¼öÁØ
  • speech interference level
    ¾ð¾î¹æÇØÄ¡, ´ëÈ­¹æÇØÄ¡
  • steady-state level
    Ç×Á¤»óżöÁØ
  • sedimentation level
    ħÀüÃþ
  • sensation level
    °¨°¢Ä¡, °¨À½Ä¡
  • sensorineural acuity level
    »ÀÀüµµÃ»·ÂÁ¤¹Ð¹®Åΰª, °ñÀüµµÃ»·ÂÁ¤¹Ð¿ªÄ¡
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • blood
    Ç÷¾×, ÇÇ
  • arterial blood
    µ¿¸ÆÇ÷¾×, µ¿¸ÆÇÇ
  • autologous blood
    ÀÚ°¡Ç÷¾×
  • blood bank
    Ç÷¾×ÀºÇà
  • blood-aqueous barrier
    Ç÷¾×¹æ¼öÀ庮
  • blood-brain barrier
    Ç÷¾×³úÀ庮
  • peripheral blood
    ¸»ÃÊÇ÷¾×
  • venous blood
    Á¤¸ÆÇ÷¾×, Á¤¸ÆÇÇ
  • whole blood
    ÀüÇ÷, ¿ÂÇ÷¾×
  • blood concentration
    Ç÷Áß³óµµ
  • blood collection
    äÇ÷
  • blood cell
    Ç÷¾×¼¼Æ÷, Ç÷±¸
  • blood count
    Ç÷±¸°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • level of significance
    À¯ÀǼöÁØ
  • maximal expiratory level
    Ãִ볯¼û¼öÁØ
  • maximal inspiratory level
    ÃÖ´ëµé¼û¼öÁØ
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • no-observed-effect level
    ¹«È¿°ú°üÂû¼öÁØ
  • noise level
    ¼ÒÀ½¼öÁØ, ÀâÀ½µµ
  • peak level
    ÃÖ°íÄ¡
  • permissible radiation exposure level
    Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
  • saturation sound pressure level
    Æ÷È­À½¾Ð¼öÁØ,
  • sedimentation level
    ħÀüÃþ
  • sensation level
    °¨À½Ä¡, °¨°¢Ä¡
  • sensorineural acuity level
    °ñµµÃ»·ÂÁ¤¹Ð¿ªÄ¡
  • sound pressure level
    À½¾Ð¼öÁØ
  • speech interference level
    ȸȭ¹æÇØÄ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • EMMIA => enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªÃøÁ¤
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò(îêëëý£áÈ).
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò(¡­ý£áÈ).
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò.
  • angiotensin converting enzyme inbibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • antibody, enzyme-labelled
    È¿¼ÒÇ¥ÁöÇ×ü
  • glycolytic enzyme
    ÇØ´çÈ¿¼Ò.
  • glycolytic enzyme
    ÇØ´çÈ¿¼Ò
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ<--Áú>È¿¼Ò¸é¿ªÇÐÀûÃøÁ¤(¹ý)
  • homogeneous enzyme immunoassay
    ±ÕÁúÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • induced enzyme
    À¯µµÈ¿¼Ò.
  • inducible enzyme
    À¯µµ(¹ß)È¿¼Ò.
  • inducible enzyme
    À¯¹ß°¡´ÉÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective perceived noise level =EPNDB
    ½ÇÈ¿°¨¼ö¼ÒÀ½(Ëà̷˧ËÛËÛËô)·¹ º§.
  • electronic energy level
    ÀüÀÚ¿¡³ÊÁöÁØÀ§(¡­ñÞêÈ).
  • excess level
    °úÀ×¼öÁØ
  • firing level
    ¹ßÈ­¼öÁØ.
  • fluid fluid level
    ¾×ü ¾×ü Ãþ
  • fluid level
    ¾×ü Ãþ
  • glucose level
    Æ÷µµ´çÄ¡<--ÁØÀ§>
  • ground water level
    ÁöÇϼö³ôÀÌ.
  • increased level
    Áõ°¡Ä¡
  • intensity level
    °­µµ¼öÁØ(Ë­öôâ©ñÞ).
  • level
    ´ë, ¼öÁØ
  • level gauge
    ¾×¸é°è(ËâËÎË­).
  • level of amputation
    Àý´Ü(ôîÓ¨)³ôÀÌ.
  • level of amputation
    Àý´Ü(ü´Ü)³ôÀÌ.
  • level of anesthesia
    ¸¶Ãë(Ø«ö­)³ôÀÌ,¸¶Ãë ±íÀÌ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Blood cells
    Ç÷¾×¼¼Æ÷ [Ç÷±¸]
    [¿¾ ¿ë¾î] Ç÷¾×¼¼Æ÷
  • Blood
    Ç÷¾× (ÇÇ)
    [¿¾ ¿ë¾î] Ç÷¾×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • MN blood group system
    MN½Ä(ãÒ)Ç÷¾×Çü(úìäûúþ)
  • P blood group
    P Ç÷¾×±º(úìäûÏØ)
  • Rh blood group system
    Rh Ç÷¾×Çü(úìäûúþ) ½Ã½ºÅÛ
  • whole blood
    ÀüÇ÷(îïúì)
  • activating enzyme
    "ºÎȰȿ¼Ò (Ý·üÀý£áÈ), Ȱ¼ºÈ­È¿¼Ò (üÀàõûùý£áÈ)"
  • acyl activating enzyme
    ¾Æ½ÇºÎȰȿ¼Ò (Ý·üÀý£áÈ)
  • acyl enzyme
    ¾Æ½ÇÈ¿¼Ò(ý£áÈ)
  • acyl enzyme intermediates
    ¾Æ½ÇÈ¿¼Ò Áß°£Ã¼(ñéÊàô÷)
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò(îêëëý£áÈ)
  • alteration enzyme
    º¯ÇüÈ¿¼Ò(ܨúþý£áÈ)
  • ambiquitous enzyme
    ¾çÁ¸È¿¼Ò(å»ðíý£áÈ)
  • amino acid activating enzyme
    ¾Æ¹Ì³ë»ê(ß«) Ȱ¼ºÈ­(üÀàõûù) È¿¼Ò(ý£áÈ)
  • amplifier enzyme
    ÁõÆøÈ¿¼Ò(ñòøëý£áÈ)
  • analogous enzyme variants
    À¯»çÈ¿¼Ò º¯ÀÌÇü(×¾ÞÄý£áÈܨì¶úþ)
  • anti-enzyme
    Ç×È¿¼Ò(ù÷ý£áÈ)Ç×ü(ù÷ô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • black blood imaging
    ÈæÇ÷·ù¿µ»ó
  • blood
    ÇÇ, Ç÷¾×
  • blood cell
    Ç÷±¸
  • blood concentration
    Ç÷Áõ³óµµ
  • blood disorder
    Ç÷¾×Áúȯ
  • blood flow
    Ç÷·ù·®
  • blood gas
    Ç÷¾×°¡½º
  • blood pool scan
    Ç÷¾×Àú·ùÁÖ»ç
  • blood stained
    ÇǼ¯ÀÎ, Çǹ¯Àº
  • blood stream
    Ç÷·ù
  • blood sugar
    Ç÷´ç
  • blood supply
    Ç÷¾×°ø±Þ
  • blood vessel
    Ç÷°ü, ÇÍÁÙ
  • blood volume
    Ç÷¾×¾ç
  • bright blood imaging
    ¸íÇ÷·ù¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CBF capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo...
HBF hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala...
CCL carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca...
CL capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ...
SAL sensorineural activity level; sterility assurance level; suction-assisted lipectomy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AL Attachment level
BiPAP Bi-level positive airway pressure
BMLD binaural masking level difference
( Ca2+ Ca2+ level
CAL Clinical Attachment Level
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subconscious level
    ÀáÀç ÀÇ½Ä ¼öÁØ
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­
  • ultrastructural level
    Ãʹ̼¼ ±¸Á¶Àû ¼öÁØ
    ÀÎü¸¦ ±¸¼ºÇÏ´Â ÃÖ¼Ò ¹Ì¼¼ ÀÔÀÚÀÇ ¼öÁØ. ±¤ÇÐÇö¹Ì°æÀÇ ÇØ»ó·ÂÀ» ³ÑÀº ÃÊÇö¹Ì°æÀ̳ª ÀüÀÚÇö¹Ì°æÇÏ¿¡¼­ óÀ½À¸·Î º¸ÀÌ´Â ±¸Á¶.
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅٽŠÀüȯ È¿¼Ò
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅٽŠÀüȯ È¿¼Ò
  • converting enzyme
    Àüȯ È¿¼Ò
  • digestive enzyme
    ¼ÒÈ­ È¿¼Ò
  • enzyme activator
    È¿¼Ò Ȱ¼ºÁ¦
  • enzyme disorder
    È¿¼Ò Àå¾Ö
  • enzyme immunoassay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
    ¼Ò·®ÀÌ¶óµµ ±× Ȱ¼ºÀ» °ËÃâÇÒ ¼ö ÀÖ´Â °í°¨µµÀÇ È¿¼Ò¸¦ Ç¥½ÃÀÚ·Î Çϰí Ç׿ø ȤÀº Ç×ü, ³ª¾Æ°¡¼­´Â ƯÀÌÀûÀ¸·Î ¹ÝÀÀÇÏ´Â ¹°Áú, lectin, C1q µîÀ» È­ÇÐÀûÀ¸·Î °áÇÕ½ÃÄÑ, Ç׿ø ȤÀº Ç×ü µûÀ§¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • enzyme inhibition
    È¿¼Ò ¾ïÁ¦
  • enzyme labeled antibody
    È¿¼Ò Ç¥Áö Ç×ü
  • enzyme marker study
    È¿¼Ò Ç¥Áö ¿¬±¸
  • enzyme precursor
    È¿¼Ò Àü±¸Ã¼
  • enzyme-labelled antibody
    È¿¼Ò Ç¥Áö Ç×ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
serum iron level A test that measures the amount of iron (Fe ++) in the blood. The test is performed when iron deficiency is suspected. Normal serum iron is 60 to 170 mcg/dl. Increased levels may be seen in the following: haemochromatosis, haemolysis, haemolytic anaemia, hepatitis, liver necrosis, haemosiderosis, iron poisoning and lead toxicity. Lower than normal levels are seen in chronic GI blood loss, iron deficiency anaemia, insufficient dietary iron, malabsorption, chronic heavy menstrual bleeding, nephrosis and late pregnancy.
(27 Sep 1997)
sound pressure level A measure of sound energy relative to 0.0002 dynes/cm2, expressed in decibels.
(05 Mar 2000)
substrate-level phosphorylation Synthesis of high-energy phosphate bonds through reaction of inorganic phosphate with an activated (usually) organic substrate.
(09 Oct 1997)
no-observed-adverse-effect level The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed)
(12 Dec 1998)
organic level The amount of organic matter prescribed to be left after logging.
(05 Dec 1998)
trophic level <biology> Stage in a food chain or web leading from primary producers (lowest trophic level) through herbivores to primary and secondary carnivores (consumers- highest level).
(09 Oct 1997)
lactate level A test that measures the amount of lactic acid in the blood. Lactic acid is an intermediate product of carbohydrate metabolism and is derived mainly from muscle cells and red blood cells. Exercise will normally raise lactic acid levels. Conditions of oxygen deprivation (for example shock, heart failure, lung disease) will trigger anaerobic metabolism within muscle tissue resulting in lactic acid build up in the tissues. Normal lactic acid levels are 4.5 to 19.8 mg/dl.
(27 Sep 1997)
lactic acid level <investigation> A test that measures the amount of lactic acid in the blood.
(25 Jun 1999)
free calcium level <biochemistry> The ionised calcium represents the calcium (Ca++) that is the metabolically active calcium. Normal values for ionised calcium in the bloodstream should be 4.4 to 5.3 mg/dl for adults and 4.4 to 6.0 mg/dl for children. Elevations may be seen in hyperparathyroidism, metastatic bone tumour, milk-alkali syndrome, multiple myeloma, Paget's disease, sarcoidosis, PTH-secreting tumours (paraneoplastic syndrome) and vitamin D intoxication. Lower than normal values may be seen in hypoparathyroidism, malabsorption, osteomalacia, pancreatitis, renal failure, rickets and vitamin D deficiency.
(27 Sep 1997)
level of aspiration <psychology> The degree or quality of performance (exhibited in a testing situation) which an individual desires to attain or feels he can achieve.
(05 Mar 2000)
acetyl-activating enzyme A ligase that catalyses the reaction of acetate and CoA and ATP to form AMP, pyrophosphate, and acetyl-CoA. A key step in the activation of acetate.
Synonym: acetate thiokinase, acetate-CoA ligase, acetyl-activating enzyme, acetyl-CoA synthetase.
(05 Mar 2000)
acyl-activating enzyme <enzyme> Fatty acid thiokinase (long-chain), a ligase forming acyl-CoA, AMP, and pyrophosphate from long-chain fatty acids, ATP, and coenzyme A. Activity is independent of phosphatidylcholine
Registry number: EC 6.2.1.3
Synonym: acyl-activating enzyme, dodecanoyl-CoA synthetase, fatty acid thiokinase (long chain), acid-coenzyme a ligase, fatty acid-CoA ligase, acyl-CoA synthetase, acyl-CoA ligase, coash ligase, ciprofibroyl-CoA synthetase, pristanoyl-CoA synthetase, palmityl CoA synthetase, palmitoyl CoA synthetase, palmitoyl CoA ligase, fatty acyl-CoA synthetase, very long chain fatty acid acyl-CoA synthetase, vlcfa acyl-CoA synthetase, nafenopin-CoA ligase, palmitoyl-CoA synthase, faa2 gene product, faa2p protein, vlacs enzyme
(26 Jun 1999)
adaptive enzyme Inducible enzyme, an enzyme that can be detected in a growing culture of a microorganism, after the addition of a particular substance (inducer) to the culture medium, but was not detectable prior to the addition and can act on the inducer. A prototype is the beta-galactosidase of Escherichia coli, synthesised upon the addition of various galactosides, whether or not these are good substrates.
Compare: constitutive enzyme.
Synonym: adaptive enzyme.
(05 Mar 2000)
allosteric enzyme <biochemistry, chemistry> A regulatory enzyme whose activity is modified by the noncovalent binding of a particular metabolite at a site (the allosteric site) other than the active site.
(09 Oct 1997)
amino acid activating enzyme <enzyme> Enzymes catalyzing the formation of a specific aminoacyl-tRNA from an amino acid and adenosine 5'-triphosphate with the concomitant formation of adenosine 5'-monophosphate and pyrophosphate.
Synonym: amino acid activating enzyme, aminoacyl-tRNA ligases.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • level
    °Ü´©´Ù;Á¶ÁØÇÏ´Ù;~ down(up)(...ÀÇ Ç¥ÁØÀ») ³·Ãß´Ù(¿Ã¸®´Ù)
  • level
    ¼öÆòÀ¸·Î ¸¸µé´Ù;°í¸£´Ù;µ¿ÀÏ ¼öÁØÀ¸·Î ¸¸µé´Ù;(°Ç¹°À») ¾²·¯¶ß¸®´Ù;(Àǵµ¸¦) µ¹¸®´Ù
  • mean sea level
    Æò±Õ ÇØ¸é(ÇØ¹ß ±âÁØ)
  • ordinary level
    G;C;E;ÀÇ ±âÃÊ Çз ½ÃÇè
  • replacement level
    Àα¸ º¸Ãæ ¼öÁØ(ÃÑÀα¸¸¦ À¯ÁöÇÏ´Â µ¥¿¡ ÇÊ¿äÇÑ Ãâ»ý·ü)
  • resistance level
    (½Ã¼¼ÀÇ)ÀúÇ×¼±(½Ã¼¼°¡ ÁÁ±â ¶§¹®¿¡ ÆÇ¸Å°¡ Ȱ¹ßÇØÁ®,±× ÀÌ»óÀÇ ½Ã¼¼ »ó½ÂÀÌ µÐÇØÁö´Â °¡°Ý ¼öÁØ)
  • sea level
    ÇØ¸é
  • spirit level
    ÁÖÁ¤ ¼öÁرâ
  • water level
    ¼öÆò¸é
  • blood
    ÇÇ(Ç÷¾×),Ç÷Åë,Ãâ»ý
  • bad blood
    ³ª»Û °¨Á¤;Áõ¿À
  • blood
    ÇÇ;Ç÷¾×;Ç÷Åë;¼øÁ¾;»ìÀ°
  • blood bank
    Ç÷¾×ÀºÇà
  • blood bath
    ´ëÇлì
  • blood brother
    Ä£ÇüÁ¦;ÇǷμ­ ¸ÎÀº ÇüÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á